How does COVID-19 contribute to cognitive impairment in older adults and future cases of dementia?
Young people write a story about themselves being unable to accomplish things. It needs to be rewritten.
What if we all knew there was a hidden safety net below us—a jeweled web to lift us when we hit rock bottom?
How can psychiatry meet its ethical duty to mitigate climate change while also promoting collegiality at conferences?
The presentation of catatonia can vary, making its management challenging, particularly in resource-limited settings in South Africa.
"As society continues to grapple with the consequences of violent behaviors, increasing efforts to understand and mitigate the risks of such behaviors using evidence-based methods and tools will be essential."
In order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.
These important findings on esketamine nasal spray as a treatment for young individuals with suicidal ideation were presented at the ACNP 2023 Annual Meeting. We interviewed the vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine to learn more.
What do these 12 Christmas symbols mean psychologically?
Andrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.
Brain Capital: a fresh approach to technologies and investing.
What happens when patients receive special treatment based on their rank or relationships? Two survivors share their stories.
There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.
D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
Panelists discuss how to diagnose postpartum depression (PPD) promptly using tools such as standardized screening questionnaires, especially in busy or resource-limited settings, and explore strategies to enhance PPD screening in underserved and minority populations in which symptoms may be underreported, while also considering the role of the case study patient’s family history in identifying her PPD symptoms.
How will the definition of assisted death (AD) as medical care impact its utilization?
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.
The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.
The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.
Bisexual individuals are at 4.5 to 6 higher risk of self harming than heterosexual individuals, according to this online study.
What are the connections between what we eat and disorders such as anxiety and depression?
In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.
Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.
Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.
In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.